Actelion shares gain on report of progress in Sanofi talks

ZURICH (Reuters) - Swiss biotech group Actelion's shares rose by more than 3 percent on Wednesday following a report that talks with Sanofi are making progress, increasing optimism that the two will strike a deal.

Actelion shares gain on report of progress in Sanofi talks
Read More


Bagikan Berita Ini